Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Accounts Payables (2020 - 2023)

Historic Accounts Payables for Candel Therapeutics (CADL) over the last 4 years, with Q3 2023 value amounting to $250000.0.

  • Candel Therapeutics' Accounts Payables fell 7422.68% to $250000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $250000.0, marking a year-over-year decrease of 7422.68%. This contributed to the annual value of $380000.0 for FY2022, which is 7610.06% down from last year.
  • Candel Therapeutics' Accounts Payables amounted to $250000.0 in Q3 2023, which was down 7422.68% from $480000.0 recorded in Q2 2023.
  • Over the past 5 years, Candel Therapeutics' Accounts Payables peaked at $1.6 million during Q4 2021, and registered a low of $250000.0 during Q3 2023.
  • Moreover, its 4-year median value for Accounts Payables was $921000.0 (2020), whereas its average is $894272.7.
  • Within the past 5 years, the most significant YoY rise in Candel Therapeutics' Accounts Payables was 10869.57% (2022), while the steepest drop was 7610.06% (2022).
  • Over the past 4 years, Candel Therapeutics' Accounts Payables (Quarter) stood at $921000.0 in 2020, then skyrocketed by 72.64% to $1.6 million in 2021, then tumbled by 76.1% to $380000.0 in 2022, then plummeted by 34.21% to $250000.0 in 2023.
  • Its Accounts Payables was $250000.0 in Q3 2023, compared to $480000.0 in Q2 2023 and $592000.0 in Q1 2023.